A New Destination for Oncology Education
September 15, 2025 | PIONEER, medical education, precision oncology
Medscape Oncology is pleased to announce the launch of a groundbreaking new learning space designed to provide education across tumor types and oncology disciplines: PIONEER – PrecIsion Oncology: Navigating EvidEnce for Real-world impact. This dedicated platform offers comprehensive, structured CME, organizing content by therapeutic target and tumor type to reflect the latest clinical and therapeutic advances. The result is a sharper focus on the science driving treatment decisions, ensuring physicians have the tools to deliver truly personalized care.
“This new learning center is all about providing clinicians with a one-stop destination for structured, consolidated CME, and helping them stay at the forefront of precision oncology to connect more patients with life-changing care. This is a vital resource for clinicians across oncology, and one we’re very proud to provide.” said Zhizhi Fiske, PhD, Director of Clinical Strategy at Medscape Education.
Surveys of Medscape physicians have found that 97% of physicians use biomarker or molecular target information when making treatment decisions. However, 85% of physicians frequently or occasionally encounter challenges in identifying appropriate therapies for patients with actionable mutations. Furthermore, 90% of physicians agree that a cross-tumor, target-based educational program would enhance their clinical decision-making.
“We surveyed over 100 physicians in the U.S. and E.U. The message was clear: doctors are eager to use biomarkers to guide treatment but struggle to keep up with rapid developments. Our findings confirm that while most find existing CME helpful, there is strong demand for interactive biomarker modules, expert panel discussions, and cross-tumor, target-based programs. A recurring theme was the desire for all these resources in one easily accessible place.” said Nabil Dorkhom, MD, Director Clinical Strategy at Medscape Education.
PIONEER is led by a distinguished steering committee of physician experts, including committee chair Fabrice André, MD, PhD, Head of Research, Professor of Oncology, Gustave Roussy, Villejuif, France; Benedikt Westphalen, MD, PhD, Chair, Center for Personalised Medicine,University Hospital, University of Munich, Munich, Germany; Vivek Subbiah, MD, Chief, Early-Phase Drug Development Sarah Cannon Research Institute,Nashville, Tennessee, United States; and Mary Beth Beasley, MD, Professor of Pathology, Head, Thoracic Pathology, Icahn School of Medicine at Mt. Sinai Medical Center, New York, United States.
“Precision oncology is revolutionizing cancer treatment, shifting from broad-spectrum therapies to precisely targeted interventions based on each patient’s unique molecular profile. For healthcare professionals, effective education and readily accessible, centralized information are paramount. This empowers them to harness cutting-edge diagnostics and apply optimized, individualized therapeutic strategies, ultimately improving patient outcomes,” commented committee chair Dr Fabrice André.
Physicians can start learning on the PIONEER microsite here.
Follow us on LinkedIn to stay up to date with the latest news and perspectives
About Medscape Education
Medscape Education is the leading online platform for continuing medical education (CME) and continuing education (CE), trusted by millions of healthcare professionals worldwide. With more than 30 speciality-specific learning destinations, it offers thousands of free, accredited courses for physicians, nurses, pharmacists, and other healthcare professionals. Medscape Education delivers high-impact, evidence-based education designed to support clinical decision-making, improve patient outcomes, and keep healthcare professionals current in a rapidly evolving medical landscape.
This content was provided by Medscape Education
Company Details
Latest Content from Medscape Education
A “Leaky Pipeline” and the Loss of Talented Female Physicians
A leaky pipeline that begins during medical school and extends throughout the training process means we lose many talented women, says Fatima Rodriguez, director of preventive cardiology and associate professor...
Medscape Oncology’s Large Presence at ASH 2023
Medscape Education is returning to the annual ASH conference with eight symposia, two publications, and the opportunity for clinicians to challenge their knowledge with MedChallenge.The eight symposia will be held...
Medscape Education Redefines Standards with Website Redesign
Medscape Education—the number 1 destination for CME—--has launched a redesign of its education hub. The site now features easy-to-navigate categories, a highlight on curricula, and enhanced search capabilities, allowing Medscape...
The Power of the Partnership: How Patient-Centricity Improves Care
How can the patient’s voice improve care?This was the question Medscape Oncology Clinical Strategist Victoria Harvey-Jones, PhD and Lesley Fallowfield DBE, BSC, DPHIL, FMEDSCI, Professor of Pyscho-Oncology, Sussex Health Outcomes...
World AIDS Day 35: Medscape’s Commitment to the Elimination of HIV through Education and Looking Towards the Future
December 1 marks the 35th year commemorating World AIDS Day, and the theme is “Remember and Commit.” While new infections have steadily declined over the last several years, HIV remains a...
Planting the Seeds for Future Women Leaders in Medicine
What are the qualities needed to be a leader in the medical field of oncology?Of course, you must be a good clinician. But you also have to be wise and...
Unmet Needs and Novel Advances at the 2023 Women’s Health Master Class
On November 8-9, Medscape Education held the 2nd Annual Women’s Health Master Class—Modernizing Women's Health: Elevating Quality Care for Everyday Practice, two days dedicated to bringing the latest advances in...
A Passionate Cause: Elevating Women to Reshape Medicine
“We need more outstanding leaders from underrepresented communities, including women and those from different ethnicities”, says Antonella Chadha Santuccione, co-founder and CEO of the nonprofit Women's Brain Project in Zurich,...